Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by Mbxwatcheron Dec 03, 2021 12:14pm
140 Views
Post# 34195304

RE:RE:RE:RE:MBX Tweets it is working on Omicron

RE:RE:RE:RE:MBX Tweets it is working on OmicronUltimately stating the obvious should not be perceived as negativity.
Raise your hand if you thought we would be at December 3rd without a repeat order from ONtario, during any of the previous newsletters or shareholder updates.
VTM was and is a big reason for the optimism in the companies future.

The fact that we do not have a repeat order 2/3rds  of the way through Q1 is not good.
In my opinion it is correctly stated, and although I quite enjoyed the last shareholder update, i really do not thinkg this was adressed well enough by Cameron.

If anyone goes back and looks at the early "VTM" guidance when the product was launched the numbers were astronomically higher than what we have actually sold.  There is no announced partnerships with other customers, and we are currently being asked to rely on the 'shelf life' of the product as comfort that all is OK.      Sorry, this cannot be spun as a positive.

Still invested fully, still strongly hopeful about the future, but VTM is a miss at this very moment, and in my opinion, this board should call a spade a spade on both sides of the ledger.

Personally, I have no issue in either blindly pumping or bashing the company, but we see some pretty good analysis on this board.  I believe highlighting VTM as a short term miss is accurate.



<< Previous
Bullboard Posts
Next >>